• Home
  • News
  • Personal Finance
    • Savings
    • Banking
    • Mortgage
    • Retirement
    • Taxes
    • Wealth
  • Make Money
  • Budgeting
  • Burrow
  • Investing
  • Credit Cards
  • Loans

Subscribe to Updates

Get the latest finance news and updates directly to your inbox.

Top News

Wall Street Sinks as Tech Rout Deepens on AI Angst

February 13, 2026

10 Skills Employers Want Most and How to Weave Them Into Your Resume

February 13, 2026

Your Sales Team Might Be Slowing Down Your Growth — Here’s Why

February 13, 2026
Facebook Twitter Instagram
Trending
  • Wall Street Sinks as Tech Rout Deepens on AI Angst
  • 10 Skills Employers Want Most and How to Weave Them Into Your Resume
  • Your Sales Team Might Be Slowing Down Your Growth — Here’s Why
  • How Steven Spielberg Transformed My Career
  • The Quiet Shift in Finance Leaders Can’t Afford to Ignore
  • LinkedIn Launches a $100/Month Integrated Sales, Marketing and Hiring Hub
  • 15 of the Best Places to Retire in the Mountains (Right Here in America)
  • How One Couple Erased $40,000 of Debt in 18 Months (Without Eating Ramen)
Friday, February 13
Facebook Twitter Instagram
iSafeSpend
Subscribe For Alerts
  • Home
  • News
  • Personal Finance
    • Savings
    • Banking
    • Mortgage
    • Retirement
    • Taxes
    • Wealth
  • Make Money
  • Budgeting
  • Burrow
  • Investing
  • Credit Cards
  • Loans
iSafeSpend
Home » Stocks to Watch: Delta Apparel, Oddity Tech, ALX Oncology
Investing

Stocks to Watch: Delta Apparel, Oddity Tech, ALX Oncology

News RoomBy News RoomOctober 3, 20230 Views0
Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Email Tumblr Telegram

By Ben Glickman

Delta Apparel said it had received an unsolicited offer to acquire its Salt Life unit. The apparel company did not say the terms of the offer, but said it would conduct a review of options for the business. Shares rise 20%, to $7.90, after-hours.

Oddity Tech said it expected its best-ever third quarter after releasing some preliminary results. The company expects revenue to grow 29% to 31%, higher than prior guidance of 18% to 23% growth. Shares rise 12%, to $31.50, after-hours.

ALX Oncology will release interim Phase 2 trial results on a call Tuesday. The company said it would discuss data from its trial of evorpacept in the treatment of HER-2-positive gastric cancer, the results of which are expected in the fourth quarter. Shares rise 22%, to $5.88, after-hours.

Write to Ben Glickman at [email protected]

Read the full article here

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Articles

How Steven Spielberg Transformed My Career

Investing February 13, 2026

The Quiet AI Threat Can Damage Your Company Without Warning

Investing February 12, 2026

How to Find a PR Agency That Actually Delivers Results

Investing February 11, 2026

Why Expertise Alone Isn’t Enough to Grow Your Business

Investing February 10, 2026

Spotify Will Sell Physical Books This Spring

Investing February 9, 2026

Build Enterprise-Grade Applications for Just $50

Investing February 8, 2026
Add A Comment

Leave A Reply Cancel Reply

Demo
Top News

10 Skills Employers Want Most and How to Weave Them Into Your Resume

February 13, 20260 Views

Your Sales Team Might Be Slowing Down Your Growth — Here’s Why

February 13, 20260 Views

How Steven Spielberg Transformed My Career

February 13, 20260 Views

The Quiet Shift in Finance Leaders Can’t Afford to Ignore

February 13, 20260 Views
Don't Miss

LinkedIn Launches a $100/Month Integrated Sales, Marketing and Hiring Hub

By News RoomFebruary 13, 2026

For many users, LinkedIn is a platform for business content and job listings. But the…

15 of the Best Places to Retire in the Mountains (Right Here in America)

February 12, 2026

How One Couple Erased $40,000 of Debt in 18 Months (Without Eating Ramen)

February 12, 2026

What Rising Through the Ranks to CEO Taught Me About Leadership at Any Scale

February 12, 2026
About Us

Your number 1 source for the latest finance, making money, saving money and budgeting. follow us now to get the news that matters to you.

We're accepting new partnerships right now.

Email Us: [email protected]

Our Picks

Wall Street Sinks as Tech Rout Deepens on AI Angst

February 13, 2026

10 Skills Employers Want Most and How to Weave Them Into Your Resume

February 13, 2026

Your Sales Team Might Be Slowing Down Your Growth — Here’s Why

February 13, 2026
Most Popular

Foundations Of Health And Longevity In Retirement

December 6, 20254 Views

Consolidate Your AI Usage and Secure Your Team 40+ AI Models Forever

November 30, 20254 Views

Spend Less and Stay Productive with This MacBook Air for Less Than $250

November 30, 20253 Views
Facebook Twitter Instagram Pinterest Dribbble
  • Privacy Policy
  • Terms of use
  • Press Release
  • Advertise
  • Contact
© 2026 iSafeSpend. All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.